What is "omixon"

Omixon is a global biotechnology company that commercializes disruptive innovations specializing in targeted applications for Next Generation Sequencing (NGS).

Omixon has been a pioneer in their approach to Human Leukocyte Antigen (HLA) data analysis, with their Omixon Target HLA Typing™ software module for NGS data. The key product Omixon now develops, Omixon Holotype HLA™, combines a targeted HLA assay and the Omixon HLA Twin™ genotyping software, to make high-resolution HLA genotyping available. The HLA region of the genome is relevant to clinical transplantation, disease association research, and pharmacogenomics, among others.

Omixon maintains an active grant-funded research program and assists scientists and clinicians to analyze the most challenging genomic regions including HLA, KIR, ABO, as well as oncology gene panels such as breast cancer, cystic fibrosis and other custom panels.